- |||||||||| Mektovi (binimetinib) / Ono Pharma, Pierre Fabre, Pfizer
New P1 trial, Combination therapy, Metastases: MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer (clinicaltrials.gov) - Jan 20, 2014 P1, N=34, Not yet recruiting,
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Enrollment open, Metastases: Phase I Trial of Combination of FOLFIRI and SOM 230 (clinicaltrials.gov) - Jan 6, 2014 P1, N=30, Recruiting, Recruiting --> Active, not recruiting Suspended --> Recruiting
- |||||||||| Erbitux (cetuximab) / Eli Lilly
Enrollment change, Metastases: FLOX + Cetuximab (Erbitux (clinicaltrials.gov) - Dec 17, 2013 P2, N=152, Completed, Completed --> Withdrawn N=86 --> 152
|